Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25

Brand: ProteoGenix

Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)

Clonality:
Monoclonal Antibody

330.00

100ug + 330 loyalty points
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)

Product name Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Aliases /Synonyms Anti-Beta-2-microglobulin, Beta-2-microglobulin form pI 5.3, B2M
Note For research use only. Not suitable for human use.
Clonality Monoclonal Antibody
Protein Name Beta-2-microglobulin, Beta-2-microglobulin form pI 5.3, B2M

Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)

The powerful tool for biotech research.

As a vital component of the immune system, B2M/Beta-2-microglobulin plays a crucial role in the recognition and elimination of foreign invaders. However, when this protein is overexpressed, it can lead to various autoimmune diseases and cancer. That’s where Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) comes in – a highly specific and potent inhibitor of B2M that can be used for a wide range of applications in biotech research.

Our Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) is a single-domain antibody derived from camelid heavy-chain antibodies. This unique structure allows for a high binding affinity and specificity towards B2M, making it a valuable tool for studying the role of B2M in various diseases and developing potential treatments.

One of the main applications of Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) is in autoimmune disease research. By inhibiting B2M, this VHH can help researchers understand the underlying mechanisms of autoimmune diseases and potentially identify new therapeutic targets.

In addition, Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) can also be used in cancer research. As B2M is often overexpressed in cancer cells, inhibiting its activity with this VHH can provide valuable insights into the role of B2M in cancer progression and may lead to the development of new anti-cancer therapies.

Our Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) has been extensively tested and validated for its effectiveness in inhibiting B2M activity in various experimental models. From cell culture studies to in vivo animal models, this VHH has consistently shown its ability to specifically target and inhibit B2M, making it a reliable tool for biotech research.

In conclusion, Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) is a powerful and versatile tool for studying the role of B2M in autoimmune diseases and cancer. With its high specificity and potency, this VHH is an essential component in any biotech research arsenal. Order now and take your research to the next level.

SDS-PAGE for Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)

SDS-PAGE for Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)

Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322), on SDS-PAGE. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products